Range
- - -
Vol / Avg.
0K/80.8K
Div / Yield
-
52 Wk
3.94 - 21.28
Mkt Cap
37.8M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.86
Shares
9.5M
Outstanding
9.5M
Total Float
-
Sector: Health Care.Industry: Health Care Equipment & Supplies
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company products are aimed at the treatment of different kinds of pulmonary hypertension.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.690-0.580 0.1100
REV0
Q4 2020Est.ActualSurprise
EPS-0.840
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BLPHBellerophon Therapeutics0%37.8M

Bellerophon Therapeutics Company Questions & Answers

Q

How do I buy Bellerophon Therapeutics (BLPH) stock?

A

You can purchase shares of Bellerophon Therapeutics (NASDAQ: BLPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bellerophon Therapeutics's (BLPH) main competitors?

A

Other companies in Bellerophon Therapeutics’s space includes: Lianluo Smart (NASDAQ:LLIT), Viveve Medical (NASDAQ:VIVE) and InVivo Therapeutics Hldg (NASDAQ:NVIV).

Q

What is the target price for Bellerophon Therapeutics?

A

The latest price target for Bellerophon Therapeutics (NASDAQ: BLPH) was reported by Jefferies on 2020-08-11. The analyst firm set a price target for 19.00 expecting BLPH to rise to within 12 months (a possible 377.39% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Bellerophon Therapeutics (BLPH) stock ?

A

The stock price for Bellerophon Therapeutics (NASDAQ: BLPH) is $3.98 last updated Wed May 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Bellerophon Therapeutics (BLPH) dividend?

A

There are no upcoming dividends for Bellerophon Therapeutics.

Q

When is Bellerophon Therapeutics (NASDAQ:BLPH) reporting earnings?

A
Bellerophon Therapeutics’s Q2 earnings are confirmed after-market from now on August 4, 2021.
Q

When is the upcoming split for BLPH?

A

There is no upcoming split for Bellerophon Therapeutics.